Dr. Carol Sabourin is Senior Research Leader and Chief Scientist at Battelle in division of Life Sciences Research. She joined Battelle in 1999 and has more than 30 years of professional experience in molecular biology, biochemistry, and molecular toxicology; and 18 years in defense research for chemical agents and infectious diseases. Her current interests are identification of biomarkers for chemical and biological agents, host immune responses for infectious diseases, and vaccine development for biological agents. As a senior scientist, she has created and implemented strategic vision for biomedical research programs at Battelle.

She is currently Principal Investigator for a National Institute of Allergy and Infectious Diseases contract, Program Director for a Biomedical Advanced Research and Development Authority contract, and Director of Non-Clinical Studies for a Department of Defense Medical Countermeasure Systems–Joint Vaccine Acquisition Program contract.

Dr. Sabourin is adjunct associate professor in the Department of Pharmacology and Toxicology in the School of Medicine at Wright State University, where she has lectured on medical chemical defense and immunotoxicology and sponsored 4 graduate students. She has been a member of SOT since 2000 and served as Secretary/Treasurer, Vice-President, and President of the Dermal Toxicology Specialty Section. She is also a member of the American College of Toxicology and American Society of Microbiology and has organized and chaired sessions for SOT and ASM. She serves on the editorial board of the Journal of Biochemical and Molecular Toxicology and as ad hoc reviewer for 15 other journals in toxicology and infectious diseases. She has served on the Material Technology Advisory Committee (MTAC) for the Department of Commerce Bureau for Industry and Security since 2007 and currently serves on the Program Committee for ASM Biothreats. She has authored/co-authored 67 peer-reviewed publications and 2 book chapters. She was elected to ATS in 2014 and her goal is to continue to expand the influence of the Academy.